Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse
2007

Influenza A Virus Vaccine Study in Mice

Sample size: 20 publication 10 minutes Evidence: moderate

Author Information

Author(s): Krystyna Mozdzanowska, Darya Zharikova, Mare Cudic, Laszlo Otvos, Walter Gerhard

Primary Institution: The Wistar Institute

Hypothesis

The study investigates the role of adjuvants and vaccination routes on antibody response and protection from influenza A virus.

Conclusion

The M2e-MAP vaccine is effective, with intranasal vaccination providing stronger protection than parenteral vaccination.

Supporting Evidence

  • Intranasal vaccination resulted in stronger protection than parenteral vaccination.
  • Approximately 15% of the antibody response was specific to the native M2e protein.
  • Adjuvants enhanced the antibody response when administered parenterally.

Takeaway

Researchers tested a new flu vaccine in mice and found that giving it through the nose worked better than giving it through a shot.

Methodology

Mice were vaccinated with M2e-MAP and challenged with influenza virus to assess antibody response and protection.

Limitations

The study was conducted in mice, which may not fully represent human responses.

Participant Demographics

Female BALB/c mice, 5-6 weeks old.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1743-422X-4-118

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication